Bonnie Biumi, a director at $CZR, bought 1,000 shares of the company on 10-31-2025 for an estimated $18,687. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 3.1%. Following this trade, they now own 32,780 shares of this class of $CZR stock.
$CZR Insider Trading Activity
$CZR insiders have traded $CZR stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CZR stock by insiders over the last 6 months:
- BONNIE BIUMI purchased 1,000 shares for an estimated $18,687
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CZR Hedge Fund Activity
We have seen 244 institutional investors add shares of $CZR stock to their portfolio, and 225 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NOMURA HOLDINGS INC added 14,145,641 shares (+11508.4%) to their portfolio in Q2 2025, for an estimated $401,594,747
- CITADEL ADVISORS LLC removed 2,592,572 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $73,603,119
- FRONTIER CAPITAL MANAGEMENT CO LLC removed 2,215,991 shares (-58.2%) from their portfolio in Q2 2025, for an estimated $62,911,984
- LOCUST WOOD CAPITAL ADVISERS, LLC removed 1,943,243 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $52,516,142
- ROYAL BANK OF CANADA added 1,686,135 shares (+92.0%) to their portfolio in Q2 2025, for an estimated $47,869,372
- ING GROEP NV removed 1,483,994 shares (-81.7%) from their portfolio in Q2 2025, for an estimated $42,130,589
- MARSHALL WACE, LLP added 1,246,600 shares (+inf%) to their portfolio in Q2 2025, for an estimated $35,390,974
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CZR Analyst Ratings
Wall Street analysts have issued reports on $CZR in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 10/29/2025
- Goldman Sachs issued a "Buy" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/29/2025
- Truist Securities issued a "Buy" rating on 10/21/2025
- JMP Securities issued a "Market Outperform" rating on 10/17/2025
- Barclays issued a "Overweight" rating on 07/30/2025
- JP Morgan issued a "Overweight" rating on 07/22/2025
To track analyst ratings and price targets for $CZR, check out Quiver Quantitative's $CZR forecast page.
$CZR Price Targets
Multiple analysts have issued price targets for $CZR recently. We have seen 10 analysts offer price targets for $CZR in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Jordan Bender from Citizens set a target price of $37.0 on 10/29/2025
- Steven Wieczynski from Stifel set a target price of $37.0 on 10/29/2025
- Daniel Politzer from JP Morgan set a target price of $38.0 on 10/29/2025
- Chad Beynon from Macquarie set a target price of $33.0 on 10/29/2025
- Barry Jonas from Truist Securities set a target price of $30.0 on 10/29/2025
- Lizzie Dove from Goldman Sachs set a target price of $25.0 on 10/29/2025
- Jordan Bender from JMP Securities set a target price of $40.0 on 10/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
